CBRE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CBRE Group Inc is not a strong buy at the moment for a beginner investor with a long-term strategy. While there are positive indicators such as hedge fund buying and a favorable analyst outlook, the technical indicators suggest the stock is overbought, and recent financial performance shows declining net income and EPS. The absence of significant news or recent Congress trading data further limits immediate catalysts for growth. It is better to wait for a more favorable entry point.
The MACD histogram is positive at 1.949, indicating bullish momentum, but it is contracting. RSI is at 82.733, signaling an overbought condition. Moving averages are converging, suggesting indecision in the market. Key resistance levels are at 148.726 and 153.042, while support levels are at 134.752 and 130.436.
Hedge funds are significantly increasing their buying activity, with a 113.38% increase in the last quarter. Analysts maintain an overall positive outlook, with multiple firms rating the stock as Overweight or Buy and price targets ranging from $170 to $198.
The stock is overbought based on RSI, and financial performance in Q4 2025 showed a decline in net income (-14.58% YoY), EPS (-12.03% YoY), and gross margin (-10.77% YoY). No recent news or Congress trading data to act as a catalyst.
In Q4 2025, revenue increased by 11.77% YoY to $11.63 billion. However, net income dropped by 14.58% YoY to $416 million, EPS fell by 12.03% YoY to 1.39, and gross margin declined by 10.77% YoY to 16.91%.
Analysts have a positive outlook on CBRE. Barclays recently raised the price target to $175, and UBS upgraded the stock to Buy with a $185 price target, citing strong industry trends and company positioning. However, some firms have lowered price targets due to weaker investor sentiment in the commercial real estate sector.
